[HTML][HTML] Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational …
HG Gowtham, M Murali, SB Singh, C Shivamallu… - Plos one, 2022 - journals.plos.org
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …
Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular …
HG Gowtham, M Murali, SB Singh, C Shivamallu… - PLoS …, 2022 - search.ebscohost.com
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …
Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular …
HG Gowtham, M Murali, SB Singh, C Shivamallu… - PLoS …, 2022 - ui.adsabs.harvard.edu
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …
[HTML][HTML] Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational …
HG Gowtham, M Murali, SB Singh, C Shivamallu… - PLoS ONE, 2022 - ncbi.nlm.nih.gov
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …
Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular …
HG Gowtham, M Murali, SB Singh… - PloS …, 2022 - pubmed.ncbi.nlm.nih.gov
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …
Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular …
HG Gowtham, M Murali, SB Singh, C Shivamallu… - Plos one, 2022 - europepmc.org
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …
Phytoconstituents of Withania somnifera unveiled ashwagandhanolide as a potential drug targeting breast cancer: investigations through computational, molecular …
HG Gowtham, M Murali, SB Singh, C Shivamallu… - 2022 - cabidigitallibrary.org
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …
Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular …
HG Gowtham, M Murali, SB Singh, C Shivamallu… - Plos one, 2022 - europepmc.org
Breast cancer is the second most common malignancy in females worldwide and poses a
great challenge that necessitates the identification of novel therapeutic agents from several …
great challenge that necessitates the identification of novel therapeutic agents from several …